Intracoronary bone marrow cell application for terminal heart failure in children

Cardiology in the Young

Volumn 22, Issue 5, 2012, Pages 558-563

  Rupp, Stefan ^a   Jux, Christian ^a   Bönig, Halvard ^b   Bauer, Jürgen ^a   Tonn, Torsten ^b,c   Seifried, Erhard ^b   Dimmeler, Stefanie ^b   Zeiher, Andreas M ^b   Schranz, Dietmar ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cardiac regeneration; dilated cardiomyopathy; heart insufficiency

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADVERSE OUTCOME; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLEEDING; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPASSIONATE USE; CONTROLLED STUDY; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TERMINAL DISEASE;

ADOLESCENT; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CORONARY VESSELS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; PILOT PROJECTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84866417680     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951112000066     Document Type: Article

References (21)

1. Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115: 3015-3038.
2. Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 1998; 101: 369-376.
3. Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003; 348: 1639-1646.
4. Alvarez J, Wilkinson JD, Lipshultz SE, for the Pediatric Cardiomyopathy Registry Study Group. Outcome predictors for pediatric dilated cardiomyopathy: a systematic review. Progress in Pediatric Cardiology 2007; 23: 25-32.
5. Almond CS, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 2009; 119: 717-727.
6. Anversa P, Leri A, Rota M, et al. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells 2007; 25: 589-601.
7. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-353.
8. Hsieh PC, Segers VF, Davis ME, et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007; 13: 970-974.
9. Rupp S, Koyanagi M, Iwasaki M, et al. Characterization of long-term endogenous cardiac repair in children after heart transplantation. Eur Heart J 2008; 29: 1867-1872.
10. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.
11. Lange R, Vogt M, Horer J, et al. Long-term results of repair of anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg 2007; 83: 1463-1471.
12. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.
13. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
14. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742-748.
15. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
16. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.
17. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-1209.
18. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-997.
19. Lipinski MJ, Biondi-Zoccai GG, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007; 50: 1761-1767.
20. Rupp S, Bauer J, Tonn T, et al. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy. Pediatr Transplant 2009; 13: 620-623.
21. Rupp S, Zeiher AM, Dimmeler S, et al. A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells. J Heart Lung Transplant 2010; 29: 574-577.